The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental and Translational Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas.
The Programme draws on the world-class research and teaching in experimental therapeutics at Oxford University and offers a unique opportunity to gain an understanding of the principles that underpin clinical research and to translate this into good clinical and research practice.
Visit the website https://www.conted.ox.ac.uk/about/msc-in-experimental-therapeutics
If your application is completed by this January deadline and you fulfil the eligibility criteria, you will be automatically considered for a graduate scholarship. For details see: http://www.ox.ac.uk/admissions/graduate/fees-and-funding/graduate-scholarships.
The MSc in Experimental and Translational Therapeutics is a part-time course consisting of six modules and a research project and dissertation. The programme is normally completed in two to three years. Students are full members of the University of Oxford and are matriculated as members of an Oxford college.
The modules in this programme can also be taken as individual short courses. It is possible to transfer credit from up to three previously completed modules into the MSc programme, if the time elapsed between commencement of the accredited module(s) and registration for the MSc is not more than two years.
- The Structure of Clinical Trials and Experimental Therapeutics
- Drug Development, Pharmacokinetics and Imaging
- Pharmacodynamics, Biomarkers and Personalised Therapy
- Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance
- How to do Research on Therapeutic Interventions: Protocol Preparation
- Biological Therapeutics
The aim of the MSc programme is to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical and research practice.
By the end of the MSc programme, students should understand the following core principles:
- Development, marketing and regulations of drugs
- Pharmaceutical factors that affect drug therapy
- Pharmacokinetics, pharmacogenetics and pharmacodynamics
- Adverse drug reactions, drug interactions, and pharmacovigilance
- Designing phase I, II and III clinical trials for a range of novel therapeutic interventions (and imaging agents).
- Application of statistics to medicine
- Laboratory assays used to support trial end-points
- Use of non-invasive imaging in drug development
- Application of analytical techniques
By the end of the programme, students should be equipped to:
- demonstrate a knowledge of the principles, methods and techniques for solving clinical research problems and translate this into good clinical and research practice
- apply skills gained in techniques and practical experience from across the medical and biological sciences
- develop skills in managing research-based work in experimental therapeutics
- carry out an extended research project involving a literature review, problem specification and analysis in experimental therapeutics and write a short dissertation
Guidance from the UK Royal College of Physician's Faculty of Pharmaceutical Medicine
The Faculty have confirmed that if enrolled for Pharmaceutical Medicine Specialty Training (PMST), trainees may be able to use knowledge provided by Experimental Therapeutics modules to cover aspects of a module of the PMST curriculum. Trainees are advised to discuss this with their Educational Supervisor.
Experimental Therapeutics modules may also be used to provide those pursuing the Faculty's Diploma in Pharmaceutical Medicine (DPM) with the necessary knowledge required to cover the Diploma syllabus. Applicants for the DPM exam are advised to read the DPM syllabus and rules and regulations.
Members of the Faculty of Pharmaceutical Medicine who are registered in the Faculty's CPD scheme can count participation in Experimental Therapeutics modules towards their CPD record. Non-members may wish to obtain further advice about CPD credit from their Royal College or Faculty.
To complete the MSc, students need to:
Attend the six modules and complete an assessed written assignment for each module.
Complete a dissertation on a topic chosen in consultation with a supervisor and the Course Director.
The dissertation is founded on a research project that builds on material studied in the taught modules. The dissertation should normally not exceed 15,000 words.
The project will normally be supervised by an academic supervisor from the University of Oxford, and an employer-based mentor.
The following are topics of dissertations completed by previous students on the course:
- The outcomes of non-surgical management of tubal pregnancy; a 6 month study of the South East London population
- Analysis of the predictive and prognostic factors of outcome in a cohort of patients prospectively treated with perioperative chemotherapy for adenocarcinoma of the stomach or of the gastroesophageal junction
- Evolution of mineral and bone disorder in early Chronic Kidney Disease (CKD): the role of FGF23 and vitamin D
- Survey of patients' knowledge and perception of the adverse drug reporting scheme (yellow cards) in primary care
- The predictive role of ERCC1 status in oxaliplatin based Neoadjuvant for metastatic colorectal cancer (CRC) to the liver
- Endothelial Pathophysiology in Dengue - Dextran studies during acute infection
- Literature review of the use of thalidomide in cancer
- An investigation into the phenotypical and functional characteristics of mesenchymal stem cells for clinical application
- Identification of genetic variants that cause capecitabine and bevacizumab toxicity
- Bridging the evidence gap in geriatric medicines via modelling and simulations
The class-based modules will include a period of preparatory study, a week of intensive face-to-face lectures and tutorials, followed by a period for assignment work. Attendance at modules will be a requirement for study. Some non-classroom activities will be provided at laboratory facilities elsewhere in the University. The course will include taught material on research skills. A virtual learning environment (VLE) will provide between-module support.
The taught modules will include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers. Practical work aims to develop the students' knowledge and understanding of the subject.
Find out how to apply here - http://www.ox.ac.uk/admissions/graduate/applying-to-oxford
This programme teaches advanced experimental approaches to dissecting the mechanisms of drug action (pharmacology), a science that has seen innovative theoretical and technical development at UCL for over a century.
In addition to providing experience of both classical and modern pharmacological techniques, the programme will help develop skills for literature search-based data acquisition and analysis; written and verbal communication of science; abstract writing; poster preparation; graphical processing; image preparation for publication; writing a scientific paper; and giving research presentations.
Students undertake modules to the value of 180 credits.
The programme consists of three core modules (75 credits), one optional module (15 credits), and a research project (90 credits).
Students choose one of the following:
Students undertake an original research project which culminates in a 15,000-word dissertation and an oral presentation.
Teaching and learning
The programme is delivered through a combination of lectures, journal clubs, practicals, tutorials and a laboratory project. Student performance is evaluated through formal examination, coursework, and the research project.
Further information on modules and degree structure is available on the department website: Experimental Pharmacology and Therapeutics MSc
This programme is likely to lead to careers in biomedical sciences, the pharmaceutical and biotechnology industry and clinical laboratories, and extend to clinicians interested in moving towards a scientific career. Students will obtain a thorough knowledge of and practice in pharmacological assessment, drug design and development pathways. It is anticipated that graduates will move onto PhD programmes and/or build careers in industry or clinical investigations through employment as research associates/scientists in the pharmaceutical industry or academia.
The knowledge and transferable skills developed on this programme will be advantageous for those considering employment in any pharmaceutical or healthcare setting, or contemplating further studies in related fields. The programme will also provide excellent training in critical appraisal of complex data, which will transfer well to other disciplines.
The programme is jointly taught by UCL Neuroscience, Physiology & Pharmacology (Division of Biosciences), and the Research Department of Pharmacology at the UCL School of Pharmacy. Both departments are historically and currently internationally leading in this field, and together provide cutting-edge education in theory, research practice and innovation in pharmacology.
The programme is designed to impart extensive experimental expertise applied to drug development and subsequent therapeutics. The combination of traditional and experimental approaches in pharmacology, coupled with current innovation in therapeutics and drug discovery and development, fosters a unique set of skills, which will enable graduates of the programme to engage in various aspects of pharmaceutical research globally.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Division of Biosciences
82% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
This research-based course has a taught component that is the same as an MSc. It provides a springboard into a career that involves a working knowledge of scientific research.
The course is designed for graduates with a BSc in the life sciences or other science disciplines, and for intercalating and fully qualified MBBS or BDS students. It can be taken either as a stand-alone qualification or as an entry route onto a PhD or MD.
The taught component of the course includes subject-specific content in the area of translational medicine and therapeutics. You have the flexibility to develop your own bespoke course by selecting additional, complementary modules. You will also participate in training in general research principles, and other professional and key skills.
Subject-based modules in translational medicine and therapeutics provide the opportunity to learn about the development and evaluation of new medicines and to develop skills in translational research relating to therapeutics. Teaching and supervision is provided by both university-based academics and experts from the pharmaceutical industry.
Your research project comprises the major element of the course. This project will involve 24 weeks of research in an area of translational medicine and therapeutics under the supervision of an expert academic researcher in the field.
The course allows you to experience an internationally competitive research area, predominantly in academia but also potentially in industry.
Translational Medicine and Therapeutics MRes is closely linked to a suite of MRes courses that you may also be interested in:
Our Medical Sciences Graduate School is dedicated to providing you with information, support and advice throughout your research degree studies. We can help and advise you on a variety of queries relating to your studies, funding or welfare.
Our Research Student Development Programme supports and complements your research whilst developing your professional skills and confidence.
You will make an on-going assessment of your own development and training needs through personal development planning (PDP) in the ePortfolio system. Our organised external events and development programme have been mapped against the Vitae Researcher Development Framework to help you identify how best to meet your training and development needs.
This pre-registration nursing programme prepares Master entry-level Registered Nurses. The admitted students are Bachelor's degree holders in any discipline. The programme prepares students for registration with the Nursing Council of Hong Kong as Registered Nurses and to acquire the attributes to become future leaders in the profession.
This is a collaborative programme of the School of Nursing, The Hong Kong Polytechnic University and the Hong Kong Sanatorium & Hospital.
The programme is accreditated by the Nursing Council of Hong Kong (NCHK) and graduates are eligible to apply for registration as Registered Nurses general.
This programme embraces all of the theoretical components required for registration with the Nursing Council of Hong Kong. These include the introductory and applied subjects, plus subjects on biology, social sciences, professional studies and humanities that develop students' broad understanding of the biological and psychosocial dimensions of the human condition and health care.
The structure runs from simple to complex, covering child and adult care, maternal care, mental health nursing, community nursing, gerontological nursing and nursing research. Students are required to complete a clinical research project in the final year to consolidate their knowledge in research in a clinical nursing focus. Supervised field practice is organized throughout the study to integrate theory into practice.
Nursing Arts and Sciences (10 subjects)
Life Sciences (3 subjects)
Humanities and Professional Studies (7 subjects)